Re-assessment of aPLs revealed a persistent high titer of aβ2GPI IgA (>400 U/ml, normal range 0–20 U/ml) with negative consensus aPLs, confirming the diagnosis of non-criteria APS and ischemic stroke secondary to the rare etiology. The gene discussed is CD79A; the disease is autoimmune polyendocrinopathy.